Loading patent…
AssigneePhotogen, Inc.
InventorsH. Craig Dees, Timothy C. Scott, Eric A. Wachter, Walter G. Fisher, John Smolik
Estimating the term…
New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.
A medicament for intracorporeal application, the medicament comprising at least one halogenated xanthene as a primary active component, wherein said medicament is useful for photodynamic treatment of human and animal tissue.
Use of a halogenated xanthene in the preparation of an intracorporeal medicament for treatment of human and animal tissue using photodynamic therapy.
Intracorporeal use of a halogenated xanthene comprising:
A pharmaceutical composition for intracorporeal administration comprising a halogenated xanthene for treatment using photodynamic therapy.
A method of treating comprising:
An intracorporeally-applicable medicament comprising at least one halogenated xanthene as a primary active component, wherein such medicament is useful for photodynamic treatment of human and animal tissue.
An intracorporeally-applicable medicament comprising at least one halogenated xanthene as a primary active component, wherein such medicament is useful for indications selected from the group consisting of conditions affecting the skin and related organs, conditions affecting the mouth and digestive tract and related organs, conditions affecting the urinary and reproductive tracts and related organs, conditions affecting the respiratory tract and related organs, conditions affecting the circulatory system and related organs, conditions affecting the head and neck, conditions affecting the endocrine and lymphoreticular systems and related organs, conditions affecting connective tissues, conditions affecting tissue surfaces exposed during surgery, and conditions related to microbial, viral, fungal, and parasitic infection.
A pharmaceutical composition adapted for intracorporeal administration to obtain a photodynamic effect, comprising a dosage unit of a halogenated xanthene and an effective amount of light.
Dependencies are inferred from the claim text.